Back in 1982, the Federalist Society was founded with the goal of pushing U.S. courts to the right. And their efforts have been successful: Although Democrats haveBack in 1982, the Federalist Society was founded with the goal of pushing U.S. courts to the right. And their efforts have been successful: Although Democrats have

Plan launched to further use of the courts to oppose Trump's agenda

2026/02/16 22:53
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Back in 1982, the Federalist Society was founded with the goal of pushing U.S. courts to the right. And their efforts have been successful: Although Democrats have won the popular vote in seven of the United States' last nine presidential elections, six of the U.S. Supreme Court's justices are GOP appointees. Three of them — Justices Brett Kavanaugh, Neil Gorsuch and Amy Coney Barrett — were championed by the Federalist Society and appointed by Donald Trump during his first presidency.

Not all of the conservatives who have been active in the Federalist Society over the years, however, are pro-MAGA. Attorney George Conway and retired Judge J. Michael Luttig are on the right but very much in the Never Trump camp.

Meanwhile, the American Constitution Society (ACS), founded at Georgetown University in Washington, DC in 2001, was modeled after the Federalist Society, but with the goal of moving the U.S. courts in a more liberal/progressive direction.

In an op-ed/essay published by the New York Times on February 16, legal expert Jeffrey Toobin stresses that the "new leadership" at ACS has "a new goal: to expand the use of the courts to oppose President Trump's agenda."

New ACS President Phil Brest, Toobin notes, helped former President Joe Biden "nominate and win confirmation of 235 federal judges."

"Those judges — and others appointed by Democratic presidents — have proved that the most effective resistance to Mr. Trump has come not from Democratic politicians, but rather, from federal judges," Toobin explains. "In the last several weeks alone, these judges, many of them Biden appointees, have ordered the release from immigration custody of five-year-old Liam Ramos and his father and their return to their home in Minnesota; blocked the Trump Administration from ending temporary protections from deportation that had been granted to thousands of Ethiopians living in the United States; and directed the Trump Administration to allow members of Congress to make unannounced visits to ICE detention facilities."

Toobin adds, "According to a Times analysis of federal appeals court rulings in 2025, judges nominated by Mr. Biden ruled in support of Mr. Trump’s policies 25 percent of the time, while those appointed by Mr. Trump supported him 92 percent of the time.

Toobin notes that when the Federalist Society was created in 1982, the "liberalism of the Warren Court era still influenced the Supreme Court." Chief Justice Earl Warren was a Republican nominee of President Dwight D. Eisenhower, yet many decisions applauded by liberal and progressives — from New York Times v. Sullivan to Griswold v. Connecticut to Stanley v. Georgia — came from the Warren Court.

In 2026, Toobin argues, Democrats need to understand what worked for the Federalist Society and use their methods to move the federal courts to the left.

"The members of the Federalist Society took the risk that Democratic legal thinkers have so far avoided," Toobin observes. "Though the Federalist Society does not as a group take formal positions on issues, the Federalists gave a platform for their clear agenda and absorbed the criticism that came with it. But when they won elections and thus seats on the Supreme Court, they knew what they wanted to do and why, and they changed the face of American law. Democrats can do the same, but first they have to try."

  • george conway
  • noam chomsky
  • civil war
  • Kayleigh mcenany
  • Melania trump
  • drudge report
  • paul krugman
  • Lindsey graham
  • Lincoln project
  • al franken bill maher
  • People of praise
  • Ivanka trump
  • eric trump
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09